BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35063442)

  • 1. Selective stabilization of the intermediate inactivated Na
    Lin YC; Lai YC; Lin TH; Yang YC; Kuo CC
    Biochem Pharmacol; 2022 Mar; 197():114928. PubMed ID: 35063442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Can an Na
    Lin YC; Lai YC; Chou P; Hsueh SW; Lin TH; Huang CS; Wang RW; Yang YC; Kuo CC
    Ann Neurol; 2021 Jun; 89(6):1099-1113. PubMed ID: 33745195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neuronal Na
    Peng YS; Wu HT; Lai YC; Chen JL; Yang YC; Kuo CC
    Neuropharmacology; 2020 Nov; 179():108266. PubMed ID: 32853658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of resurgent Na
    Chen JL; Kuo CC
    Neuropharmacology; 2024 Apr; 247():109835. PubMed ID: 38228283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rufinamide attenuates mechanical allodynia in a model of neuropathic pain in the mouse and stabilizes voltage-gated sodium channel inactivated state.
    Suter MR; Kirschmann G; Laedermann CJ; Abriel H; Decosterd I
    Anesthesiology; 2013 Jan; 118(1):160-72. PubMed ID: 23221868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lamotrigine on Na(v)1.4 voltage-gated sodium channels.
    Nakatani Y; Masuko H; Amano T
    J Pharmacol Sci; 2013; 123(2):203-6. PubMed ID: 24096830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones.
    Kuo CC; Lu L
    Br J Pharmacol; 1997 Jul; 121(6):1231-8. PubMed ID: 9249262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranolazine reduces neuronal excitability by interacting with inactivated states of brain sodium channels.
    Kahlig KM; Hirakawa R; Liu L; George AL; Belardinelli L; Rajamani S
    Mol Pharmacol; 2014 Jan; 85(1):162-74. PubMed ID: 24202911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation.
    Niespodziany I; Leclère N; Vandenplas C; Foerch P; Wolff C
    J Neurosci Res; 2013 Mar; 91(3):436-43. PubMed ID: 23239147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V102862 (Co 102862): a potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels.
    Ilyin VI; Hodges DD; Whittemore ER; Carter RB; Cai SX; Woodward RM
    Br J Pharmacol; 2005 Mar; 144(6):801-12. PubMed ID: 15778702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brivaracetam differentially affects voltage-gated sodium currents without impairing sustained repetitive firing in neurons.
    Niespodziany I; André VM; Leclère N; Hanon E; Ghisdal P; Wolff C
    CNS Neurosci Ther; 2015 Mar; 21(3):241-51. PubMed ID: 25444522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced availability of voltage-gated sodium channels by depolarization or blockade by tetrodotoxin boosts burst firing and catecholamine release in mouse chromaffin cells.
    Vandael DH; Ottaviani MM; Legros C; Lefort C; Guérineau NC; Allio A; Carabelli V; Carbone E
    J Physiol; 2015 Feb; 593(4):905-27. PubMed ID: 25620605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
    Hebeisen S; Pires N; Loureiro AI; Bonifácio MJ; Palma N; Whyment A; Spanswick D; Soares-da-Silva P
    Neuropharmacology; 2015 Feb; 89():122-35. PubMed ID: 25242737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rufinamide Improves Functional and Behavioral Deficits via Blockade of Tetrodotoxin-Resistant Sodium Channels in Diabetic Neuropathy.
    Kharatmal SB; Singh JN; Sharma SS
    Curr Neurovasc Res; 2015; 12(3):262-8. PubMed ID: 26036975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burst kinetics of sodium channels which lack fast inactivation in mouse neuroblastoma cells.
    Quandt FN
    J Physiol; 1987 Nov; 392():563-85. PubMed ID: 2451730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons.
    Nakamura M; Cho JH; Shin H; Jang IS
    Eur J Pharmacol; 2019 Jul; 855():175-182. PubMed ID: 31063770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of voltage-gated Na+ channels by hinokiol in neuronal cells.
    Wang YW; Yang CT; Gong CL; Chen YH; Chen YW; Wu KC; Cheng TH; Kuo YH; Chen YF; Leung YM
    Pharmacol Rep; 2015 Dec; 67(6):1049-54. PubMed ID: 26481521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice.
    Striano P; McMurray R; Santamarina E; Falip M
    Epileptic Disord; 2018 Feb; 20(1):13-29. PubMed ID: 29313492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rufinamide.
    Arroyo S
    Neurotherapeutics; 2007 Jan; 4(1):155-62. PubMed ID: 17199032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage-gated sodium channels: pharmaceutical targets via anticonvulsants to treat epileptic syndromes.
    Abdelsayed M; Sokolov S
    Channels (Austin); 2013; 7(3):146-52. PubMed ID: 23531742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.